Christiane Amendt

1.1k total citations
24 papers, 926 citations indexed

About

Christiane Amendt is a scholar working on Oncology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Christiane Amendt has authored 24 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Molecular Biology and 4 papers in Computational Theory and Mathematics. Recurrent topics in Christiane Amendt's work include HER2/EGFR in Cancer Research (5 papers), DNA Repair Mechanisms (4 papers) and Computational Drug Discovery Methods (4 papers). Christiane Amendt is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), DNA Repair Mechanisms (4 papers) and Computational Drug Discovery Methods (4 papers). Christiane Amendt collaborates with scholars based in Germany, United States and Australia. Christiane Amendt's co-authors include Peter Schirmacher, Willi Jahnen‐Dechent, Werner Müller‐Esterl, Thorsten Schinke, Frank T. Zenke, H. Wéber, Manfred Blessing, M Blessing, Amrit Mann and Claudia Wilm and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Christiane Amendt

23 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christiane Amendt Germany	12	440	294	162	114	102	24	926
Satoru Shinriki Japan	24	850 1.9×	568 1.9×	82 0.5×	142 1.2×	102 1.0×	59	1.5k
Yonglong Zou United States	11	658 1.5×	250 0.9×	371 2.3×	80 0.7×	107 1.0×	16	1.2k
Ida Katrine Lund Denmark	18	335 0.8×	264 0.9×	45 0.3×	32 0.3×	90 0.9×	43	839
Ron Zeheb United States	13	384 0.9×	190 0.6×	21 0.1×	84 0.7×	70 0.7×	17	775
Christophe Lebœuf France	24	604 1.4×	443 1.5×	19 0.1×	71 0.6×	188 1.8×	74	1.6k
Alessandro Malara Italy	21	215 0.5×	75 0.3×	48 0.3×	105 0.9×	198 1.9×	38	1.2k
Shou‐Ih Hu United States	10	387 0.9×	239 0.8×	60 0.4×	50 0.4×	31 0.3×	10	836
Eva Cubillo Spain	9	794 1.8×	528 1.8×	16 0.1×	109 1.0×	115 1.1×	10	1.1k
Kanji Hojo Japan	11	560 1.3×	242 0.8×	39 0.2×	85 0.7×	93 0.9×	21	974
Beatrice Belmonte Italy	18	410 0.9×	322 1.1×	28 0.2×	45 0.4×	167 1.6×	61	1.1k

Countries citing papers authored by Christiane Amendt

Since Specialization

Citations

This map shows the geographic impact of Christiane Amendt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christiane Amendt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christiane Amendt more than expected).

Fields of papers citing papers by Christiane Amendt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christiane Amendt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christiane Amendt. The network helps show where Christiane Amendt may publish in the future.

Co-authorship network of co-authors of Christiane Amendt

This figure shows the co-authorship network connecting the top 25 collaborators of Christiane Amendt. A scholar is included among the top collaborators of Christiane Amendt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christiane Amendt. Christiane Amendt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neumann, F., Julia Jabs, Christian Sirrenberg, et al.. (2024). Peposertib, a DNA-PK Inhibitor, Enhances the Anti-Tumor Efficacy of Topoisomerase II Inhibitors in Triple-Negative Breast Cancer Models. International Journal of Molecular Sciences. 25(10). 5120–5120. 3 indexed citations

Amendt, Christiane, et al.. (2024). Abstract ND08: M3554, a novel anti-GD2 antibody drug conjugate. Cancer Research. 84(7_Supplement). ND08–ND08. 5 indexed citations

Budzinska, Magdalena A., Olga Bogatyrova, F. Neumann, et al.. (2023). DNA-Dependent Protein Kinase Inhibitor Peposertib Potentiates the Cytotoxicity of Topoisomerase II Inhibitors in Synovial Sarcoma Models. Cancers. 16(1). 189–189. 2 indexed citations

Zutshi, Anup, Berend Neuteboom, Christine Knuehl, et al.. (2022). Abstract 5423: Translational PK/PD/efficacy modeling and efficacious human dose prediction for a first-in-class MUC1-EGFR (M1231) bispecific antibody drug conjugate. Cancer Research. 82(12_Supplement). 5423–5423. 7 indexed citations

Knuehl, Christine, Lars Toleikis, Edith Ross, et al.. (2022). Abstract 5284: M1231 is a bispecific anti-MUC1xEGFR antibody-drug conjugate designed to treat solid tumors with MUC1 and EGFR co-expression. Cancer Research. 82(12_Supplement). 5284–5284. 19 indexed citations

Zenke, Frank T., Astrid Zimmermann, Christian Sirrenberg, et al.. (2020). Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models. Molecular Cancer Therapeutics. 19(5). 1091–1101. 118 indexed citations

Alimzhanov, Marat, Patricia Soulard, Astrid Zimmermann, et al.. (2019). Abstract 2269: ATR inhibitor M6620 enhances anti-tumor efficacy of the combination of the anti-PD-L1 antibody avelumab with platinum-based chemotherapy. Immunology. 2269–2269. 2 indexed citations

Almquist, J.O., Mats Jirstrand, Alexandre Sostelly, et al.. (2016). Tumor Static Concentration Curves in Combination Therapy. The AAPS Journal. 19(2). 456–467. 17 indexed citations

Sostelly, Alexandre, et al.. (2015). Modelling and Analysis of Tumor Growth Inhibition for Combination Therapy using Tumor Static Concentration Curves. Chalmers Publication Library (Chalmers University of Technology). 1 indexed citations

10.

Amendt, Christiane, Eike Staub, Manja Friese‐Hamim, Stephan Störkel, & Christopher Stroh. (2014). Association of EGFR Expression Level and Cetuximab Activity in Patient-Derived Xenograft Models of Human Non–Small Cell Lung Cancer. Clinical Cancer Research. 20(17). 4478–4487. 13 indexed citations

11.

Kubach, Jan, Mario Hubo, Christiane Amendt, Christopher Stroh, & Helmut Jonuleit. (2014). IgG1 anti‐epidermal growth factor receptor antibodies induce CD8‐dependent antitumor activity. International Journal of Cancer. 136(4). 821–830. 19 indexed citations

12.

Buchstaller, Hans‐Peter, Lars T. Burgdorf, Dirk Finsinger, et al.. (2011). Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(8). 2264–2269. 17 indexed citations

13.

Schiemann, Kai, Dirk Finsinger, Frank T. Zenke, et al.. (2010). The discovery and optimization of hexahydro-2H-pyrano[3,2-c]quinolines (HHPQs) as potent and selective inhibitors of the mitotic kinesin-5. Bioorganic & Medicinal Chemistry Letters. 20(5). 1491–1495. 56 indexed citations

14.

Sirrenberg, Christian, Hans‐Michael Eggenweiler, Hans‐Peter Buchstaller, et al.. (2010). Abstract 2639: Discovery of novel small molecule inhibitors of Hsp90 for oral treatment. Cancer Research. 70(8_Supplement). 2639–2639. 1 indexed citations

15.

Orth, James D., Jue Shi, Clement T. Loy, et al.. (2008). Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate. Molecular Cancer Therapeutics. 7(11). 3480–3489. 91 indexed citations

16.

Kleespies, Axel, Ivan Ischenko, Martin Eichhorn, et al.. (2008). Matuzumab Short-Term Therapy in Experimental Pancreatic Cancer: Prolonged Antitumor Activity in Combination with Gemcitabine. Clinical Cancer Research. 14(17). 5426–5436. 10 indexed citations

17.

Amendt, Christiane, Maximilian Peters, Maksim Yezhelyev, et al.. (2003). In vivo activity of humanized monoclonal anti-EGFR antibody EMD72000 in combination with gemcitabine on growth of primary pancreatic tumors and metastases in an orthotopic nude mouse model. 44. 1234. 11 indexed citations

18.

Amendt, Christiane, Amrit Mann, Peter Schirmacher, & Manfred Blessing. (2002). Resistance of keratinocytes to TGFβ-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds. Journal of Cell Science. 115(10). 2189–2198. 104 indexed citations

19.

Amendt, Christiane, Peter Schirmacher, H. Wéber, & M Blessing. (1998). Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene. 17(1). 25–34. 103 indexed citations

20.

Schinke, Thorsten, et al.. (1996). The Serum Protein α2-HS Glycoprotein/Fetuin Inhibits Apatite Formation in Vitro and in Mineralizing Calvaria Cells. Journal of Biological Chemistry. 271(34). 20789–20796. 302 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact